Published in World J Surg on March 01, 2005
Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells. Eur J Histochem (2010) 0.89
Expression pattern of thymosin beta 4 in the adult human liver. Eur J Histochem (2011) 0.89
Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study. World J Gastroenterol (2006) 0.88
Thymosin beta4 and Ac-SDKP: tools to mend a broken heart. J Mol Med (Berl) (2007) 0.85
Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer (2013) 0.82
Thymostimulin in advanced hepatocellular carcinoma: a phase II trial. BMC Cancer (2008) 0.80
Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma. Haematologica (2009) 0.79
AcSDKP: a new potential marker of malignancy of the thyroid gland. Langenbecks Arch Surg (2006) 0.79
High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy. World J Surg Oncol (2014) 0.79
The Escherichia coli-derived thymosin β4 concatemer promotes cell proliferation and healing wound in mice. Biomed Res Int (2013) 0.77
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. Br J Cancer (2012) 0.77
Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity. Int J Biol Sci (2011) 0.77
A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing. Drug Des Devel Ther (2013) 0.76
Genomic analysis of metastasis reveals an essential role for RhoC. Nature (2000) 10.11
The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J (1991) 4.96
Functional coherence of the human Y chromosome. Science (1997) 4.15
Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat Med (1996) 1.94
Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci U S A (1981) 1.90
beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol (2001) 1.89
Interaction of thymosin beta 4 with muscle and platelet actin: implications for actin sequestration in resting platelets. Biochemistry (1992) 1.73
Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues. Proc Natl Acad Sci U S A (1982) 1.56
HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat Med (1996) 1.54
The actin binding site of thymosin beta 4 mapped by mutational analysis. EMBO J (1996) 1.50
Thymosin beta4 accelerates wound healing. J Invest Dermatol (1999) 1.50
Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J (1997) 1.46
The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc Natl Acad Sci U S A (1986) 1.43
ENHANCEMENT OF IN VIVO INCORPORATION OF LABELED PRECURSORS INTO DNA AND TOTAL PROTEIN OF MOUSE LYMPH NODES AFTER ADMINISTRATION OF THYMIC EXTRACTS. Proc Natl Acad Sci U S A (1965) 1.40
Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med (1999) 1.37
Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem (1993) 1.33
Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. J Cell Biol (1992) 1.33
Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem (1996) 1.32
Thymosin stimulates secretion of luteinizing hormone-releasing factor. Science (1981) 1.31
Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A (1992) 1.29
Modulation of the interaction between G-actin and thymosin beta 4 by the ATP/ADP ratio: possible implication in the regulation of actin dynamics. Proc Natl Acad Sci U S A (1993) 1.26
The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J (2003) 1.24
Prothymosin alpha: a biologically active protein with random coil conformation. Biochemistry (1995) 1.22
Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1. J Immunol (1982) 1.21
Distribution of prothymosin alpha in rat tissues. Proc Natl Acad Sci U S A (1984) 1.20
Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene (1993) 1.19
Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol (2002) 1.18
Effects of thymosin beta 4 and thymosin beta 10 on actin structures in living cells. Cell Motil Cytoskeleton (1994) 1.18
T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann N Y Acad Sci (1979) 1.12
Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene (2003) 1.12
Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer (1991) 1.10
Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol (1999) 1.10
Primary structure of rat thymus prothymosin alpha. Proc Natl Acad Sci U S A (1985) 1.10
Prothymosin alpha modulates the interaction of histone H1 with chromatin. Nucleic Acids Res (1998) 1.09
Prothymosin alpha antisense oligomers inhibit myeloma cell division. Proc Natl Acad Sci U S A (1991) 1.07
Age-related changes in localization of thymosin in the human thymus. Thymus (1982) 1.07
Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res (1998) 1.07
Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis (1999) 1.07
Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes. J Immunol (1987) 1.04
Expression of the prothymosin-a gene as a prognostic factor in lung cancer. Surg Today (2001) 1.03
Determination of thymosin beta 4 in human blood cells and serum. J Chromatogr (1987) 1.03
Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells. Biochem J (1998) 1.01
Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum. Int J Immunopharmacol (1986) 1.01
Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J Immunol (1987) 1.01
Nuclear targeting of prothymosin alpha. J Biol Chem (1991) 1.01
Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma. Int J Cancer (1993) 1.01
Tbeta 4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentration. J Biol Chem (1996) 1.00
Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J Cell Sci (1995) 1.00
Synthesis of thymosin beta 4 by peritoneal macrophages and adherent spleen cells. Proc Natl Acad Sci U S A (1982) 0.98
Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem J (1998) 0.98
Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization. Int J Oncol (2002) 0.96
Prothymosin alpha in human blood. Proc Natl Acad Sci U S A (1987) 0.96
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application. Int J Immunopharmacol (2000) 0.95
Prothymosin alpha and parathymosin: mRNA and polypeptide levels in rodent tissues. Arch Biochem Biophys (1989) 0.95
Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription. EMBO Rep (2002) 0.95
Thymic hormones--a clinical update. Springer Semin Immunopathol (1986) 0.95
Prothymosin alpha functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro. J Biol Chem (2000) 0.95
Prothymosin alpha promotes cell proliferation in NIH3T3 cells. Life Sci (1997) 0.94
Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action. Proc Natl Acad Sci U S A (1990) 0.94
Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants. Immunology (2003) 0.93
Biosynthesis rates and content of thymosin beta 4 in cell lines. Arch Biochem Biophys (1985) 0.92
Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes. Int J Immunopharmacol (1990) 0.91
Prothymosin alpha is an evolutionary conserved protein covalently linked to a small RNA. FEBS Lett (1989) 0.91
Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes. Immunopharmacology (1989) 0.91
Interaction of G-actin with thymosin beta 4 and its variants thymosin beta 9 and thymosin beta met9. J Muscle Res Cell Motil (1994) 0.91
Isolation and structural characterization of thymosin-beta 4 from a human medullary thyroid carcinoma. J Endocrinol (1988) 0.91
Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen (2003) 0.90
Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue. Mod Pathol (1997) 0.89
Interactions of beta-thymosins, thymosin beta 4-sulfoxide, and N-terminally truncated thymosin beta 4 with actin studied by equilibrium centrifugation, chemical cross-linking and viscometry. Eur J Biochem (1995) 0.88
Thymosin beta 4 (T beta 4) in activated platelets. Eur J Cell Biol (1993) 0.88
Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes. Int J Immunopharmacol (1989) 0.87
Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol (1998) 0.87
Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas. Jpn J Clin Oncol (2002) 0.87
Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br J Cancer (1997) 0.87
beta-Thymosins are not simple actin monomer buffering proteins. Insights from overexpression studies. J Biol Chem (1996) 0.87
Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Br J Cancer (1996) 0.86
Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes. Immunology (1989) 0.86
Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signal. FEBS Lett (1997) 0.85
Increasing intracellular concentrations of thymosin beta 4 in PtK2 cells: effects on stress fibers, cytokinesis, and cell spreading. Cell Motil Cytoskeleton (1995) 0.85
Thymosin treatment modulates production of interferon. J Interferon Res (1981) 0.85
Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1984) 0.84
Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells. Biochem Biophys Res Commun (2002) 0.84
Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by N alpha-desacetylthymosin alpha 1. Eur J Immunol (1982) 0.83
Rapid induction of thymosin beta 4 in concanavalin A-stimulated thymocytes by translational control. J Biol Chem (1990) 0.82
Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1. Eur J Immunol (1987) 0.82
Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem Biophys Res Commun (1993) 0.82
Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. Biochem Biophys Res Commun (1996) 0.82
Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta4. Cell Motil Cytoskeleton (1997) 0.82
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer. Int Immunopharmacol (2003) 0.82
Use of bimanyl actin derivative (TMB-actin) for studying complexation of beta-thymosins. Inhibition of actin polymerization by thymosin beta 9. FEBS Lett (1993) 0.82
Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reaction. Immunopharmacology (1987) 0.81
Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma. Cancer Lett (2001) 0.81
Thymic physiology and biochemistry. Adv Clin Chem (1987) 0.81
Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology (2000) 0.80
Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation. J Immunol (1992) 0.80
Multiple tRNA attachment sites in prothymosin alpha. FEBS Lett (1999) 0.79
Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha. Cancer Immunol Immunother (1995) 0.79
Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis (1998) 0.79
Evidence that thymosins and other biologic response modifiers can function as neuroactive immunotransmitters. J Immunol (1985) 0.79
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell (2011) 11.44
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature (2011) 6.73
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med (2012) 5.25
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res (2009) 3.87
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet (2009) 3.59
Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology (2010) 3.57
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia. Blood (2006) 3.48
RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell (2008) 3.44
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med (2013) 3.40
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci U S A (2012) 3.03
Complete genome sequence of Yersinia pestis strain 91001, an isolate avirulent to humans. DNA Res (2004) 2.95
Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem (2010) 2.93
Functional genomics of genes with small open reading frames (sORFs) in S. cerevisiae. Genome Res (2006) 2.81
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol (2008) 2.71
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 2.70
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation (2012) 2.54
Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol (2005) 2.51
Essential Staphylococcus aureus toxin export system. Nat Med (2013) 2.50
Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol (2009) 2.44
Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes. J Clin Oncol (2013) 2.42
Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg (2009) 2.31
High accuracy information extraction of medication information from clinical notes: 2009 i2b2 medication extraction challenge. J Am Med Inform Assoc (2010) 2.29
Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J Hepatol (2013) 2.14
High-efficiency InGaN-based LEDs grown on patterned sapphire substrates. Opt Express (2011) 2.14
Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. J Gen Physiol (2010) 2.09
Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A (2002) 2.08
Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta (2009) 2.08
Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol (2004) 2.04
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia. Blood (2008) 2.04
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood (2006) 1.98
Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up. Cerebrovasc Dis (2013) 1.97
A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem (2001) 1.97
Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc Natl Acad Sci U S A (2012) 1.97
Defining cell-type specificity at the transcriptional level in human disease. Genome Res (2013) 1.96
Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension (2012) 1.92
Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell (2010) 1.92
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther (2008) 1.90
Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell (2003) 1.90
Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell (2007) 1.89
Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives. Chem Pharm Bull (Tokyo) (2008) 1.83
Adaptive diversification of bitter taste receptor genes in Mammalian evolution. Mol Biol Evol (2003) 1.82
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A (2007) 1.81
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am J Physiol Lung Cell Mol Physiol (2009) 1.81
Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc Natl Acad Sci U S A (2003) 1.81
p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev Biol (2006) 1.81
MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res (2013) 1.80
The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology (2008) 1.79
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol (2002) 1.78
Ego3 functions as a homodimer to mediate the interaction between Gtr1-Gtr2 and Ego1 in the ego complex to activate TORC1. Structure (2012) 1.77
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol (2009) 1.77
Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling. Blood (2013) 1.70
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet (2010) 1.69
The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS One (2010) 1.67
A permissive role of mushroom body α/β core neurons in long-term memory consolidation in Drosophila. Curr Biol (2012) 1.67
Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci U S A (2005) 1.65
G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. J Gen Physiol (2007) 1.64
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood (2008) 1.63
A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci (2013) 1.63
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther (2010) 1.63
Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains. J Physiol (2002) 1.62
Dynamic reprogramming of chromatin accessibility during Drosophila embryo development. Genome Biol (2011) 1.61
MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med (2011) 1.59
Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer (2006) 1.59
Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet (2005) 1.57
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies. Blood (2013) 1.56
Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds. Trends Pharmacol Sci (2008) 1.54
Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett (2007) 1.53
Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol (2012) 1.53
DNA microarray analysis of genome dynamics in Yersinia pestis: insights into bacterial genome microevolution and niche adaptation. J Bacteriol (2004) 1.52
To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med (2011) 1.52
Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med (2009) 1.51
[Effects of different statin regimens on lipid profile and serum metalloproteinases in patients with coronary heart disease]. Zhonghua Xin Xue Guan Bing Za Zhi (2009) 1.50
Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage. Cancer Biol Ther (2010) 1.50
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery. Thromb Haemost (2010) 1.47
Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm Res (2004) 1.47
Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet (2011) 1.46
The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol (2006) 1.46
An orthophosphate semiconductor with photooxidation properties under visible-light irradiation. Nat Mater (2010) 1.46
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res (2006) 1.45
Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk. Cancer Cell (2011) 1.44
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis. Gene (2012) 1.44
Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res (2007) 1.43
Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer (2010) 1.43
The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation. J Biol Chem (2006) 1.43